NT-INF-001

N/A

Report date: 2026/05/12 09:17:20

Base Information

Drug NameNT-INF-001

Drug Alias NameRSV mRNA疫苗（嘉译生物）NT-INF-001NTINF001

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[5]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRespiratory Syncytial Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesJiayi Biomedicine (Hangzhou) Co., Ltd.

China Registration ClassN/A

Develop Information

Active CompaniesJiayi Biomedicine (Hangzhou) Co., Ltd.

Inactive CompaniesN/A

Active IndicationsRespiratory Syncytial Virus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A